Get startedLog in
    Picture of Neurizon Therapeutics logo

    NUZ — Neurizon Therapeutics News Story

    0.000.00%
    au flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapMomentum Trap
    All News

    Brief: Pharmaust Says To Undertake Phase 2 Study In Covid-19 Rather Than A Phase 1 Study

    Picture of Neurizon Therapeutics logoNeurizon Therapeutics
    24/05/2022 24:07
    May 24 (Reuters) - Pharmaust Ltd  PAA.AX :
    * TO UNDERTAKE A PHASE 2 STUDY IN COVID-19 RATHER THAN A
PHASE 1
STUDY

Source text for Eikon:  ID:nASXbJXvMr 
Further company coverage:  PAA.AX

    Recent news on Neurizon Therapeutics

    See all news